LCAT is most likely to inhibit LGG tumor progression by affecting focal adhesion formation (Figure 13C); LCAT is most likely to inhibit LIHC tumor progression through glycine, serine, and threonine metabolism (Figure 13D). The gene discussed is LCAT; the disease is neoplasm.